Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

OXiGENE initiates U.S. preclinical and clinical research

May 2, 1997

Targeted Genetics' E1A tumor suppressor gene product progresses in clinical trials

May 2, 1997

Natural compounds that inhibit oncogene function from Terumo

May 2, 1997

Schering-Plough develops potent farnesyltransferase inhibitor

April 30, 1997

NCI identifies compounds effective against aggressive human tumors

April 30, 1997

Potent antitumor farnesyltransferase inhibitors discovered by Parke-Davis

April 29, 1997

PD-170262: potent and selective PDGF TK inhibitor from Parke-Davis

April 29, 1997

Radiosensitizing taxanes prepared by Florida State University

April 29, 1997

Agents for hyperandrogenic disorders from Merck & Co.

April 29, 1997

RPR describes novel farnesyltransferase inhibitors

April 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...